BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 14612491)

  • 21. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
    Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis.
    Hayama S; Daigo Y; Kato T; Ishikawa N; Yamabuki T; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y
    Cancer Res; 2006 Nov; 66(21):10339-48. PubMed ID: 17079454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.
    Ishikawa N; Daigo Y; Takano A; Taniwaki M; Kato T; Tanaka S; Yasui W; Takeshima Y; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Cancer Sci; 2006 Aug; 97(8):737-45. PubMed ID: 16863507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.
    Taniwaki M; Daigo Y; Ishikawa N; Takano A; Tsunoda T; Yasui W; Inai K; Kohno N; Nakamura Y
    Int J Oncol; 2006 Sep; 29(3):567-75. PubMed ID: 16865272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A selective requirement for copper-dependent activation of cytochrome c oxidase by Cox17p.
    Kako K; Takehara A; Arai H; Onodera T; Takahashi Y; Hanagata H; Ogra Y; Takagi H; Kodama H; Suzuki KT; Munekata E; Fukamizu A
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1379-85. PubMed ID: 15504366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
    Bartling B; Lewensohn R; Zhivotovsky B
    Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.
    Dai Z; Popkie AP; Zhu WG; Timmers CD; Raval A; Tannehill-Gregg S; Morrison CD; Auer H; Kratzke RA; Niehans G; Amatschek S; Sommergruber W; Leone GW; Rosol T; Otterson GA; Plass C
    Oncogene; 2004 Apr; 23(20):3521-9. PubMed ID: 15116090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
    Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
    Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
    J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer.
    Yageta M; Kuramochi M; Masuda M; Fukami T; Fukuhara H; Maruyama T; Shibuya M; Murakami Y
    Cancer Res; 2002 Sep; 62(18):5129-33. PubMed ID: 12234973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
    Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
    J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis.
    Peikert T; Specks U; Farver C; Erzurum SC; Comhair SA
    Cancer Res; 2006 May; 66(9):4693-700. PubMed ID: 16651421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.